https://www.selleckchem.com/EGFR(HER).html
Osteosarcoma is the most common malignant bone tumour and the second leading cause of cancer‑related death in children and adolescents. Microwave ablation has an excellent therapeutic effect on bone tumours by instantaneously increasing the temperature in the tumour; however, there is a risk of damaging the surrounding healthy tissues by exposure to a high temperature when the treatment power is too large. In the present study, two anti‑tumour reagents, a heat shock protein 90 (HSP9 inhibitor (PF‑04929113) and a transforming growth factor‑β1
Aimer
Commentaire
Partagez
